Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine and Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Am Heart J. 2019 Oct;216:62-73. doi: 10.1016/j.ahj.2019.07.002. Epub 2019 Jul 13.
High-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) at the time of myocardial infarction (MI) are strong predictors of prognosis. However, whether their premorbid (before MI occurrence) levels are associated with prognosis after incident MI is unknown.
In 1,054 participants from the Atherosclerosis Risk in Communities Study with incident MI, we evaluated premorbid levels of hs-cTnT and NT-proBNP measured on median 5.8 (interquartile interval 3.0-11.5 [mean 5.5]) years prior to incident MI and their associations with subsequent composite and individual outcomes of all-cause mortality, cardiovascular mortality, recurrent MI, heart failure, and stroke.
During a median follow-up of 3.0 years after MI, 801 participants developed the composite outcome. Both hs-cTnT and NT-proBNP were independently associated with the composite outcome after incident MI. Among individual outcomes, all-cause mortality, cardiovascular mortality, and heart failure showed significant associations with both cardiac markers. Overall, NT-proBNP demonstrated a more evident relationship than hs-cTnT. Indeed, the addition of premorbid NT-proBNP alone, but not hs-cTnT alone, to conventional predictors at incident MI significantly improved risk prediction of the composite outcome after incident MI (Δc-statistic 0.013 [95% CI 0.005-0.022] from 0.691 with conventional predictors).
Premorbid levels of hs-cTnT and NT-proBNP assessed on average 6 years prior to incident MI were associated with adverse outcomes after incident MI. These results further highlight the importance of cardiac health at an earlier stage of life.
心肌梗死(MI)时高敏心肌肌钙蛋白 T(hs-cTnT)和 N 末端 pro-B 型利钠肽(NT-proBNP)是预后的强预测因子。然而,它们在发生 MI 之前(发生 MI 之前)的水平是否与 MI 后事件的预后相关尚不清楚。
在 ARIC 研究中的 1054 名发生 MI 的参与者中,我们评估了发生 MI 前中位数 5.8 年(四分位距 3.0-11.5[平均 5.5])测量的 hs-cTnT 和 NT-proBNP 的预发病水平,及其与所有原因死亡率、心血管死亡率、复发性 MI、心力衰竭和中风等随后的复合和个体结局的关系。
在 MI 后中位 3.0 年的随访期间,801 名参与者发生了复合结局。hs-cTnT 和 NT-proBNP 在发生 MI 后均与复合结局独立相关。在个别结局中,全因死亡率、心血管死亡率和心力衰竭与两种心脏标志物均有显著关联。总的来说,NT-proBNP 与 hs-cTnT 相比显示出更明显的关系。事实上,仅在发生 MI 时添加预发病 NT-proBNP 而不是 hs-cTnT ,可显著提高发生 MI 后复合结局的风险预测(从包含传统预测因子的 0.691 增加 0.013[95%CI 0.005-0.022])。
发生 MI 前平均 6 年评估的 hs-cTnT 和 NT-proBNP 的预发病水平与发生 MI 后不良结局相关。这些结果进一步强调了生命早期心脏健康的重要性。